Balanced Portfolio Recommendation: Buy – CSL Ltd (CSL)
CSL is also very close to trial results for a heart attack drug CSL112, a key pipeline product for CSL. Base case assumptions imply a valuation of around $30/share.
CSL is also very close to trial results for a heart attack drug CSL112, a key pipeline product for CSL. Base case assumptions imply a valuation of around $30/share.
Equities finished generally lower on Friday on continuing geopolitical pressure weighing on the market into a weekend.
China’s unchanged consumer inflation in September and declining producer prices signal potential economic challenges, amidst a property crisis and waning consumer confidence.
The CPI rose to 0.4% in September, taking the annual rate to 3.7%, slightly above expectations for a 0.3% and 3.6% rise respectively.
Amidst the Israel-Hamas conflict, oil prices waver, while the Reserve Bank of Australia contemplates a potential rate hike in its upcoming November meeting.
Anticipating next week’s US company earnings updates. Key insights, market reactions, and expert analysis. Stay informed on the latest financial updates and trends.
Investors shrugged off PPI (Producer Price Index) data pointing to an uptick in the pace of inflation as equities gained ahead of the key CPI
Anticipating next week’s ASX company earnings release. Key insights, market reactions, and expert analysis. Stay informed on the latest financial updates and trends.
Australian and US bond yields reflect growing sentiments against rate hikes. Meanwhile, Israel signals a potential ground assault, escalating Middle East tensions.
Equites closed higher on Tuesday after dovish comments from U.S. Federal Reserve officials pushed Treasury yields lower while investors cautiously monitored developments in the Middle East.
The S&P/ASX 200 rallies past 7000, influenced by US Federal Reserve’s stance and NAB’s inflation insights, with all sectors, especially utilities and energy, registering gains.
Equites edged higher as investors bought the early-day weakness after weighing up a more cautious tone rate hike from Federal Reserve officials and rising geopolitical tensions amid fears the Israel-Hamas conflict.